CharalamposFloudasMDDMSc, MS

Oncology • Bethesda, MD

Head & Neck Cancer

Assistant Research Physician, NCI/NIH

Join to view full profile

Dr. Floudas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Floudas' full profile

Already have an account?

Office
10 Center Drive
Rm 13N240
Bethesda, MD 20892
Is this information wrong?

Education & Training

Maimonides Medical CenterResidency, Internal Medicine, 2013 - 2016
University of Crete School of Health SciencesClass of 2000

Certifications & Licensure

MD State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

14 citations
Corrigendum: Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy.
Vivek Kumar, Neha Chaudhary, Mohit Garg, Charalampos S Floudas, Parita Soni
Frontiers in Pharmacology. 2017-01-01
19 citations
Vemurafenib in leptomeningeal carcinomatosis from melanoma: a case report of near-complete response and prolonged survival.
Charalampos S. Floudas, Abhinav B. Chandra, Yiqing Xu
Melanoma Research. 2016-06-01
151 citations
Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy.
Vivek Kumar, Neha Chaudhary, Mohit Garg, Charalampos S Floudas, Parita Soni
Frontiers in Pharmacology. 2017-01-01

Press Mentions

Study in India Could Make Immunotherapy More Affordable WorldwideNovember 22nd, 2022
Precigen Reports Second Quarter and First Half 2021 Financial ResultsAugust 9th, 2021